ALXN
Massachusetts Financial Services’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-111,383
| Closed | -$15.6M | – | 882 |
|
|
2017
Q3 | $15.6M | Sell |
111,383
-54
| -0% | -$7.58K | 0.01% | 531 |
|
|
2017
Q2 | $13.6M | Sell |
111,437
-532,714
| -83% | -$64.8M | 0.01% | 556 |
|
|
2017
Q1 | $78.1M | Sell |
644,151
-7,236
| -1% | -$877K | 0.04% | 295 |
|
|
2016
Q4 | $79.7M | Sell |
651,387
-1,017,804
| -61% | -$125M | 0.04% | 280 |
|
|
2016
Q3 | $205M | Sell |
1,669,191
-428,883
| -20% | -$52.6M | 0.1% | 187 |
|
|
2016
Q2 | $245M | Buy |
2,098,074
+368,335
| +21% | +$43M | 0.12% | 168 |
|
|
2016
Q1 | $241M | Sell |
1,729,739
-392,606
| -18% | -$54.7M | 0.13% | 167 |
|
|
2015
Q4 | $405M | Buy |
2,122,345
+163,168
| +8% | +$31.1M | 0.22% | 126 |
|
|
2015
Q3 | $306M | Sell |
1,959,177
-189,463
| -9% | -$29.6M | 0.17% | 137 |
|
|
2015
Q2 | $388M | Sell |
2,148,640
-226,610
| -10% | -$41M | 0.2% | 122 |
|
|
2015
Q1 | $412M | Buy |
2,375,250
+81,276
| +4% | +$14.1M | 0.21% | 111 |
|
|
2014
Q4 | $424M | Buy |
2,293,974
+166,817
| +8% | +$30.9M | 0.22% | 108 |
|
|
2014
Q3 | $353M | Buy |
2,127,157
+13,164
| +0.6% | +$2.18M | 0.19% | 126 |
|
|
2014
Q2 | $330M | Buy |
2,113,993
+282,872
| +15% | +$44.2M | 0.17% | 131 |
|
|
2014
Q1 | $279M | Buy |
1,831,121
+45,940
| +3% | +$6.99M | 0.15% | 144 |
|
|
2013
Q4 | $237M | Buy |
1,785,181
+426,376
| +31% | +$56.7M | 0.13% | 156 |
|
|
2013
Q3 | $158M | Buy |
1,358,805
+209,018
| +18% | +$24.3M | 0.1% | 192 |
|
|
2013
Q2 | $106M | Buy |
+1,149,787
| New | +$106M | 0.07% | 224 |
|